ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Ovarian Cancer
Breast Cancer
Carcinoma
Triple Negative Breast Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Epithelial Carcinoma

Endometrial Cancer trials near Paris, Île-de-France, FRA:

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features (RAINBO)

The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...

Enrolling
Endometrial Cancer
Radiation: Vaginal brachytherapy
Drug: Megestrol Acetate

Phase 2, Phase 3

Leiden University Medical Center (LUMC)

Villejuif, France and 13 other locations

This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...

Enrolling
Endometrial Cancer
Malignant Solid Tumour
Drug: Doxorubicin
Drug: Puxitatug Samrotecan

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 153 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Paris, France and 65 other locations

Locations recently updated

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 242 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Nab-paclitaxel

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Paris, France and 243 other locations

study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...

Active, not recruiting
Endometrial Cancer
Drug: Carboplatin-Paclitaxel
Drug: Dostarlimab

Phase 3

ARCAGY/ GINECO GROUP

Paris, France and 94 other locations

The RAINBO program is a studies group which proposes personalized treatment of patients suffering from endometrial cancer according...

Enrolling
Endometrial Cancer
P53abn
Drug: Olaparib (300 mg BID)

Phase 3

Gustave Roussy

Paris, France and 14 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Enrolling
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

Paris, France and 186 other locations

non-resectable metastatic or locally advanced non-colorectal and non-endometrial cancers compared to the standard of care chemother...

Enrolling
Soft Tissue Sarcoma
Adrenocortical Carcinoma
Drug: Dostarlimab
Drug: Chemotherapy

Phase 2

Unicancer
Unicancer

Paris, Île-de-France, France and 21 other locations

drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Paris, France and 73 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems